Overall market sentiment has been neutral on Cue Biopharma Inc (CUE) stock lately. CUE receives a Neutral rating from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company.
Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive.
InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend.
Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .
What's Happening With CUE Stock Today?
Cue Biopharma Inc (CUE) stock is trading at $15.86 as of 11:56 AM on Monday, Oct 19, a rise of $0.18, or 1.15% from the previous closing price of $15.68. The stock has traded between $15.75 and $16.98 so far today. Volume today is low. So far 69,672 shares have traded compared to average volume of 269,938 shares.
To screen for more stocks like Cue Biopharma Inc click here.
More About Cue Biopharma Inc
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant form of the cytokine Interleukin-2 and a T cell antigen to target and activate T cells specific to HPV-related cancers.
Click Here to get the full Stock Score Report on Cue Biopharma Inc (CUE) Stock.
